Baidu
map
INT J CANCER 润色咨询

INTERNATIONAL JOURNAL OF CANCER

出版年份：暂无数据 年文章数：9003 投稿命中率： 开通期刊会员，数据随心看

出版周期：Semimonthly 自引率：2.5% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收 编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床<br>经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178059, encodeId=9cc621e8059f0, content=偏重的研究方向：DNA损伤修复<br>经验分享：想问问大家投综述结果怎么样 不是约稿的 目前review了 也会给比较多的意见么 还是回来直接拒的那种 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05565589730, createdName=ms3000001161396804, createdTime=Fri Dec 29 23:19:12 CST 2023, time=2023-12-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2200790, encodeId=b1a72200e9029, content=投过3次，第一次18天一审回来，中，快接收时候要实验原始数据 第二次under consideration 5天后秒拒 第三次 3个月一审回来，中，一开始under consideration 9天后要求改格式并上传实验原始数据，然后才送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b65125344, createdName=146449eem63暂无昵称, createdTime=Sat Apr 27 23:06:31 CST 2024, time=2024-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241409, encodeId=2384124140980, content=偏重的研究方向：肿瘤;biomarker<br>经验分享：请问各位大佬，我的投稿状态，从under evaluation，变成了awaiting decision，这种情况属于是什么阶段呢？我看评论里都是修改之后才有的awaiting decision，我这个是要被拒了么？还是继续等着呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Sat Aug 27 21:12:04 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research<br>经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature<br>经验分享：2022.09.02 submitted<br>2022.09.04 under evaluation<br>2022.09.12 under review<br>2022.09.20 under evaluation<br>2022.09.21 under review<br>2022.10.20 awaiting decision<br>2022.10.25 major revision<br>2022.11.19 resubmission<br>2022.11.21 under review<br>2022.12.2 under evaluation<br>2022.12.6 under review<br>2022.12.7 awaiting decision<br>2022.12.8 accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2120726, encodeId=18a62120e268e, content=请问一般under evaluation几天呀，已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90f98527616, createdName=ms3000001615675881, createdTime=Tue Mar 21 10:52:33 CST 2023, time=2023-03-21, status=1, ipAttribution=弗吉尼亚)]
    2021-09-04 凶巴巴恰北北怪兽

    7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收 编辑很友好

    17

    展开17条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收 编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床<br>经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178059, encodeId=9cc621e8059f0, content=偏重的研究方向：DNA损伤修复<br>经验分享：想问问大家投综述结果怎么样 不是约稿的 目前review了 也会给比较多的意见么 还是回来直接拒的那种 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05565589730, createdName=ms3000001161396804, createdTime=Fri Dec 29 23:19:12 CST 2023, time=2023-12-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2200790, encodeId=b1a72200e9029, content=投过3次，第一次18天一审回来，中，快接收时候要实验原始数据 第二次under consideration 5天后秒拒 第三次 3个月一审回来，中，一开始under consideration 9天后要求改格式并上传实验原始数据，然后才送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b65125344, createdName=146449eem63暂无昵称, createdTime=Sat Apr 27 23:06:31 CST 2024, time=2024-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241409, encodeId=2384124140980, content=偏重的研究方向：肿瘤;biomarker<br>经验分享：请问各位大佬，我的投稿状态，从under evaluation，变成了awaiting decision，这种情况属于是什么阶段呢？我看评论里都是修改之后才有的awaiting decision，我这个是要被拒了么？还是继续等着呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Sat Aug 27 21:12:04 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research<br>经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature<br>经验分享：2022.09.02 submitted<br>2022.09.04 under evaluation<br>2022.09.12 under review<br>2022.09.20 under evaluation<br>2022.09.21 under review<br>2022.10.20 awaiting decision<br>2022.10.25 major revision<br>2022.11.19 resubmission<br>2022.11.21 under review<br>2022.12.2 under evaluation<br>2022.12.6 under review<br>2022.12.7 awaiting decision<br>2022.12.8 accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2120726, encodeId=18a62120e268e, content=请问一般under evaluation几天呀，已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90f98527616, createdName=ms3000001615675881, createdTime=Tue Mar 21 10:52:33 CST 2023, time=2023-03-21, status=1, ipAttribution=弗吉尼亚)]
    2022-04-26 ms9000000399989409

    偏重的研究方向：肿瘤;Cancer;临床
    经验分享：问一下大家under evaluation都持续几天呢?

    5

    展开5条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收 编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床<br>经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178059, encodeId=9cc621e8059f0, content=偏重的研究方向：DNA损伤修复<br>经验分享：想问问大家投综述结果怎么样 不是约稿的 目前review了 也会给比较多的意见么 还是回来直接拒的那种 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05565589730, createdName=ms3000001161396804, createdTime=Fri Dec 29 23:19:12 CST 2023, time=2023-12-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2200790, encodeId=b1a72200e9029, content=投过3次，第一次18天一审回来，中，快接收时候要实验原始数据 第二次under consideration 5天后秒拒 第三次 3个月一审回来，中，一开始under consideration 9天后要求改格式并上传实验原始数据，然后才送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b65125344, createdName=146449eem63暂无昵称, createdTime=Sat Apr 27 23:06:31 CST 2024, time=2024-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241409, encodeId=2384124140980, content=偏重的研究方向：肿瘤;biomarker<br>经验分享：请问各位大佬，我的投稿状态，从under evaluation，变成了awaiting decision，这种情况属于是什么阶段呢？我看评论里都是修改之后才有的awaiting decision，我这个是要被拒了么？还是继续等着呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Sat Aug 27 21:12:04 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research<br>经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature<br>经验分享：2022.09.02 submitted<br>2022.09.04 under evaluation<br>2022.09.12 under review<br>2022.09.20 under evaluation<br>2022.09.21 under review<br>2022.10.20 awaiting decision<br>2022.10.25 major revision<br>2022.11.19 resubmission<br>2022.11.21 under review<br>2022.12.2 under evaluation<br>2022.12.6 under review<br>2022.12.7 awaiting decision<br>2022.12.8 accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2120726, encodeId=18a62120e268e, content=请问一般under evaluation几天呀，已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90f98527616, createdName=ms3000001615675881, createdTime=Tue Mar 21 10:52:33 CST 2023, time=2023-03-21, status=1, ipAttribution=弗吉尼亚)]
    2023-12-29 ms3000001161396804 来自黑龙江省

    偏重的研究方向：DNA损伤修复
    经验分享：想问问大家投综述结果怎么样 不是约稿的 目前review了 也会给比较多的意见么 还是回来直接拒的那种 谢谢

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收 编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床<br>经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178059, encodeId=9cc621e8059f0, content=偏重的研究方向：DNA损伤修复<br>经验分享：想问问大家投综述结果怎么样 不是约稿的 目前review了 也会给比较多的意见么 还是回来直接拒的那种 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05565589730, createdName=ms3000001161396804, createdTime=Fri Dec 29 23:19:12 CST 2023, time=2023-12-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2200790, encodeId=b1a72200e9029, content=投过3次，第一次18天一审回来，中，快接收时候要实验原始数据 第二次under consideration 5天后秒拒 第三次 3个月一审回来，中，一开始under consideration 9天后要求改格式并上传实验原始数据，然后才送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b65125344, createdName=146449eem63暂无昵称, createdTime=Sat Apr 27 23:06:31 CST 2024, time=2024-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241409, encodeId=2384124140980, content=偏重的研究方向：肿瘤;biomarker<br>经验分享：请问各位大佬，我的投稿状态，从under evaluation，变成了awaiting decision，这种情况属于是什么阶段呢？我看评论里都是修改之后才有的awaiting decision，我这个是要被拒了么？还是继续等着呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Sat Aug 27 21:12:04 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research<br>经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature<br>经验分享：2022.09.02 submitted<br>2022.09.04 under evaluation<br>2022.09.12 under review<br>2022.09.20 under evaluation<br>2022.09.21 under review<br>2022.10.20 awaiting decision<br>2022.10.25 major revision<br>2022.11.19 resubmission<br>2022.11.21 under review<br>2022.12.2 under evaluation<br>2022.12.6 under review<br>2022.12.7 awaiting decision<br>2022.12.8 accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2120726, encodeId=18a62120e268e, content=请问一般under evaluation几天呀，已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90f98527616, createdName=ms3000001615675881, createdTime=Tue Mar 21 10:52:33 CST 2023, time=2023-03-21, status=1, ipAttribution=弗吉尼亚)]
    2024-04-27 146449eem63暂无昵称 来自上海

    投过3次，第一次18天一审回来，中，快接收时候要实验原始数据 第二次under consideration 5天后秒拒 第三次 3个月一审回来，中，一开始under consideration 9天后要求改格式并上传实验原始数据，然后才送审

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收 编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床<br>经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178059, encodeId=9cc621e8059f0, content=偏重的研究方向：DNA损伤修复<br>经验分享：想问问大家投综述结果怎么样 不是约稿的 目前review了 也会给比较多的意见么 还是回来直接拒的那种 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05565589730, createdName=ms3000001161396804, createdTime=Fri Dec 29 23:19:12 CST 2023, time=2023-12-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2200790, encodeId=b1a72200e9029, content=投过3次，第一次18天一审回来，中，快接收时候要实验原始数据 第二次under consideration 5天后秒拒 第三次 3个月一审回来，中，一开始under consideration 9天后要求改格式并上传实验原始数据，然后才送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b65125344, createdName=146449eem63暂无昵称, createdTime=Sat Apr 27 23:06:31 CST 2024, time=2024-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241409, encodeId=2384124140980, content=偏重的研究方向：肿瘤;biomarker<br>经验分享：请问各位大佬，我的投稿状态，从under evaluation，变成了awaiting decision，这种情况属于是什么阶段呢？我看评论里都是修改之后才有的awaiting decision，我这个是要被拒了么？还是继续等着呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Sat Aug 27 21:12:04 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research<br>经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature<br>经验分享：2022.09.02 submitted<br>2022.09.04 under evaluation<br>2022.09.12 under review<br>2022.09.20 under evaluation<br>2022.09.21 under review<br>2022.10.20 awaiting decision<br>2022.10.25 major revision<br>2022.11.19 resubmission<br>2022.11.21 under review<br>2022.12.2 under evaluation<br>2022.12.6 under review<br>2022.12.7 awaiting decision<br>2022.12.8 accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2120726, encodeId=18a62120e268e, content=请问一般under evaluation几天呀，已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90f98527616, createdName=ms3000001615675881, createdTime=Tue Mar 21 10:52:33 CST 2023, time=2023-03-21, status=1, ipAttribution=弗吉尼亚)]
    2024-01-11 ms6000000445449810 来自北京

    求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收 编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床<br>经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178059, encodeId=9cc621e8059f0, content=偏重的研究方向：DNA损伤修复<br>经验分享：想问问大家投综述结果怎么样 不是约稿的 目前review了 也会给比较多的意见么 还是回来直接拒的那种 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05565589730, createdName=ms3000001161396804, createdTime=Fri Dec 29 23:19:12 CST 2023, time=2023-12-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2200790, encodeId=b1a72200e9029, content=投过3次，第一次18天一审回来，中，快接收时候要实验原始数据 第二次under consideration 5天后秒拒 第三次 3个月一审回来，中，一开始under consideration 9天后要求改格式并上传实验原始数据，然后才送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b65125344, createdName=146449eem63暂无昵称, createdTime=Sat Apr 27 23:06:31 CST 2024, time=2024-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241409, encodeId=2384124140980, content=偏重的研究方向：肿瘤;biomarker<br>经验分享：请问各位大佬，我的投稿状态，从under evaluation，变成了awaiting decision，这种情况属于是什么阶段呢？我看评论里都是修改之后才有的awaiting decision，我这个是要被拒了么？还是继续等着呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Sat Aug 27 21:12:04 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research<br>经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature<br>经验分享：2022.09.02 submitted<br>2022.09.04 under evaluation<br>2022.09.12 under review<br>2022.09.20 under evaluation<br>2022.09.21 under review<br>2022.10.20 awaiting decision<br>2022.10.25 major revision<br>2022.11.19 resubmission<br>2022.11.21 under review<br>2022.12.2 under evaluation<br>2022.12.6 under review<br>2022.12.7 awaiting decision<br>2022.12.8 accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2120726, encodeId=18a62120e268e, content=请问一般under evaluation几天呀，已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90f98527616, createdName=ms3000001615675881, createdTime=Tue Mar 21 10:52:33 CST 2023, time=2023-03-21, status=1, ipAttribution=弗吉尼亚)]
    2018-12-21 bicia

    投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收 编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床<br>经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178059, encodeId=9cc621e8059f0, content=偏重的研究方向：DNA损伤修复<br>经验分享：想问问大家投综述结果怎么样 不是约稿的 目前review了 也会给比较多的意见么 还是回来直接拒的那种 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05565589730, createdName=ms3000001161396804, createdTime=Fri Dec 29 23:19:12 CST 2023, time=2023-12-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2200790, encodeId=b1a72200e9029, content=投过3次，第一次18天一审回来，中，快接收时候要实验原始数据 第二次under consideration 5天后秒拒 第三次 3个月一审回来，中，一开始under consideration 9天后要求改格式并上传实验原始数据，然后才送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b65125344, createdName=146449eem63暂无昵称, createdTime=Sat Apr 27 23:06:31 CST 2024, time=2024-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241409, encodeId=2384124140980, content=偏重的研究方向：肿瘤;biomarker<br>经验分享：请问各位大佬，我的投稿状态，从under evaluation，变成了awaiting decision，这种情况属于是什么阶段呢？我看评论里都是修改之后才有的awaiting decision，我这个是要被拒了么？还是继续等着呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Sat Aug 27 21:12:04 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research<br>经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature<br>经验分享：2022.09.02 submitted<br>2022.09.04 under evaluation<br>2022.09.12 under review<br>2022.09.20 under evaluation<br>2022.09.21 under review<br>2022.10.20 awaiting decision<br>2022.10.25 major revision<br>2022.11.19 resubmission<br>2022.11.21 under review<br>2022.12.2 under evaluation<br>2022.12.6 under review<br>2022.12.7 awaiting decision<br>2022.12.8 accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2120726, encodeId=18a62120e268e, content=请问一般under evaluation几天呀，已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90f98527616, createdName=ms3000001615675881, createdTime=Tue Mar 21 10:52:33 CST 2023, time=2023-03-21, status=1, ipAttribution=弗吉尼亚)]
    2022-08-27 ms5000001852951271

    偏重的研究方向：肿瘤;biomarker
    经验分享：请问各位大佬，我的投稿状态，从under evaluation，变成了awaiting decision，这种情况属于是什么阶段呢？我看评论里都是修改之后才有的awaiting decision，我这个是要被拒了么？还是继续等着呢？

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收 编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床<br>经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178059, encodeId=9cc621e8059f0, content=偏重的研究方向：DNA损伤修复<br>经验分享：想问问大家投综述结果怎么样 不是约稿的 目前review了 也会给比较多的意见么 还是回来直接拒的那种 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05565589730, createdName=ms3000001161396804, createdTime=Fri Dec 29 23:19:12 CST 2023, time=2023-12-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2200790, encodeId=b1a72200e9029, content=投过3次，第一次18天一审回来，中，快接收时候要实验原始数据 第二次under consideration 5天后秒拒 第三次 3个月一审回来，中，一开始under consideration 9天后要求改格式并上传实验原始数据，然后才送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b65125344, createdName=146449eem63暂无昵称, createdTime=Sat Apr 27 23:06:31 CST 2024, time=2024-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241409, encodeId=2384124140980, content=偏重的研究方向：肿瘤;biomarker<br>经验分享：请问各位大佬，我的投稿状态，从under evaluation，变成了awaiting decision，这种情况属于是什么阶段呢？我看评论里都是修改之后才有的awaiting decision，我这个是要被拒了么？还是继续等着呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Sat Aug 27 21:12:04 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research<br>经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature<br>经验分享：2022.09.02 submitted<br>2022.09.04 under evaluation<br>2022.09.12 under review<br>2022.09.20 under evaluation<br>2022.09.21 under review<br>2022.10.20 awaiting decision<br>2022.10.25 major revision<br>2022.11.19 resubmission<br>2022.11.21 under review<br>2022.12.2 under evaluation<br>2022.12.6 under review<br>2022.12.7 awaiting decision<br>2022.12.8 accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2120726, encodeId=18a62120e268e, content=请问一般under evaluation几天呀，已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90f98527616, createdName=ms3000001615675881, createdTime=Tue Mar 21 10:52:33 CST 2023, time=2023-03-21, status=1, ipAttribution=弗吉尼亚)]
    2023-03-31 Linyan Yu 来自山东省

    偏重的研究方向：肿瘤相关;Environmental Research
    经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激

    4

    展开4条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收 编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床<br>经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178059, encodeId=9cc621e8059f0, content=偏重的研究方向：DNA损伤修复<br>经验分享：想问问大家投综述结果怎么样 不是约稿的 目前review了 也会给比较多的意见么 还是回来直接拒的那种 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05565589730, createdName=ms3000001161396804, createdTime=Fri Dec 29 23:19:12 CST 2023, time=2023-12-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2200790, encodeId=b1a72200e9029, content=投过3次，第一次18天一审回来，中，快接收时候要实验原始数据 第二次under consideration 5天后秒拒 第三次 3个月一审回来，中，一开始under consideration 9天后要求改格式并上传实验原始数据，然后才送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b65125344, createdName=146449eem63暂无昵称, createdTime=Sat Apr 27 23:06:31 CST 2024, time=2024-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241409, encodeId=2384124140980, content=偏重的研究方向：肿瘤;biomarker<br>经验分享：请问各位大佬，我的投稿状态，从under evaluation，变成了awaiting decision，这种情况属于是什么阶段呢？我看评论里都是修改之后才有的awaiting decision，我这个是要被拒了么？还是继续等着呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Sat Aug 27 21:12:04 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research<br>经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature<br>经验分享：2022.09.02 submitted<br>2022.09.04 under evaluation<br>2022.09.12 under review<br>2022.09.20 under evaluation<br>2022.09.21 under review<br>2022.10.20 awaiting decision<br>2022.10.25 major revision<br>2022.11.19 resubmission<br>2022.11.21 under review<br>2022.12.2 under evaluation<br>2022.12.6 under review<br>2022.12.7 awaiting decision<br>2022.12.8 accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2120726, encodeId=18a62120e268e, content=请问一般under evaluation几天呀，已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90f98527616, createdName=ms3000001615675881, createdTime=Tue Mar 21 10:52:33 CST 2023, time=2023-03-21, status=1, ipAttribution=弗吉尼亚)]
    2022-12-08 yousuosaki 来自海南省

    偏重的研究方向：mutational signature
    经验分享：2022.09.02 submitted
    2022.09.04 under evaluation
    2022.09.12 under review
    2022.09.20 under evaluation
    2022.09.21 under review
    2022.10.20 awaiting decision
    2022.10.25 major revision
    2022.11.19 resubmission
    2022.11.21 under review
    2022.12.2 under evaluation
    2022.12.6 under review
    2022.12.7 awaiting decision
    2022.12.8 accepted

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收 编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床<br>经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178059, encodeId=9cc621e8059f0, content=偏重的研究方向：DNA损伤修复<br>经验分享：想问问大家投综述结果怎么样 不是约稿的 目前review了 也会给比较多的意见么 还是回来直接拒的那种 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05565589730, createdName=ms3000001161396804, createdTime=Fri Dec 29 23:19:12 CST 2023, time=2023-12-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2200790, encodeId=b1a72200e9029, content=投过3次，第一次18天一审回来，中，快接收时候要实验原始数据 第二次under consideration 5天后秒拒 第三次 3个月一审回来，中，一开始under consideration 9天后要求改格式并上传实验原始数据，然后才送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b65125344, createdName=146449eem63暂无昵称, createdTime=Sat Apr 27 23:06:31 CST 2024, time=2024-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241409, encodeId=2384124140980, content=偏重的研究方向：肿瘤;biomarker<br>经验分享：请问各位大佬，我的投稿状态，从under evaluation，变成了awaiting decision，这种情况属于是什么阶段呢？我看评论里都是修改之后才有的awaiting decision，我这个是要被拒了么？还是继续等着呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Sat Aug 27 21:12:04 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research<br>经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature<br>经验分享：2022.09.02 submitted<br>2022.09.04 under evaluation<br>2022.09.12 under review<br>2022.09.20 under evaluation<br>2022.09.21 under review<br>2022.10.20 awaiting decision<br>2022.10.25 major revision<br>2022.11.19 resubmission<br>2022.11.21 under review<br>2022.12.2 under evaluation<br>2022.12.6 under review<br>2022.12.7 awaiting decision<br>2022.12.8 accepted<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2120726, encodeId=18a62120e268e, content=请问一般under evaluation几天呀，已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90f98527616, createdName=ms3000001615675881, createdTime=Tue Mar 21 10:52:33 CST 2023, time=2023-03-21, status=1, ipAttribution=弗吉尼亚)]
    2023-03-21 ms3000001615675881 来自弗吉尼亚

    请问一般under evaluation几天呀，已经10天了

    1

    展开1条回复
共500条页码: 1/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map